For the fifth time, the Swiss National Science Foundation (SNSF) is launching a call for targeted funding of investigator-initiated clinical studies that are outside the industry focus. The SNSF recommends drawing up the study protocol with help from local Clinical Trial Units. 

The special programme for Investigator Initiated Clinical Trials (IICTs) of the Swiss National Science Foundation supports clinical studies on documented but underresearched medical needs. Though important for patients, these study topics remain outside the industry focus. The IICT programme does not provide support for non-randomised and uncontrolled studies.

Submission deadline is 1 November 2019. Find out more about the call at www.snf.ch.

Show more

Hide

With its 3rd call for proposals, Personalized Health and Related Technologies (PHRT) invites clinical scientists who have access to an extensive sample cohort, to create an inter-institutional, interdisciplinary consortium to formulate a well-defined clinical question to request funding to generate matched genomic, transcriptomic, and proteomic data by the two PHRT platforms. Data integration, data analysis and data interpretation form an important part of the project, as well.

The submission deadline for the proposals of the 3rd call is 27 May 2019. The relevant documents describing the characteristics of this pioneering project and its requirements, well as detailed description of the general goals, scope, mode of operation, and project types of PHRT can be found at PHRT. 

Who is behind PHRT?
PHRT is a strategic focus area of the ETH Domain that fosters personalised health research in collaboration with hospitals and clinics, with CHF 50 million for 2017-2020. It offers technological know-how, expertise, and capacity from the ETH Domain institutions to medical and clinical partners by supporting collaborative interdisciplinary research.

What is personalised medicine?
The primary objective of personalised medicine is to recognise a human disease as a complex system and to achieve an integral and comprehensive understanding of this system at the molecular level, to select optimised treatment for each individual. The study of disease systems in this framework generally requires interdisciplinary, inter-institutional cooperation between basic scientists, data scientists, clinicians, and other disciplines.

Show more

Hide

The Biobanking and BioMolecular resources Research Infrastructure (BBMRI), the European Research Infrastructure for Translational Medicine (EATRIS), and the European Clinical Research Infrastructure Network (ECRIN) signed an agreement in the last week of February in Brussels to build a long-term sustainable collaboration strategy.

The agreement lays the ground for facilitating user access to pan-European medical research infrastructures and supporting the development of tools, joint services, and common approaches on quality, standards, and advocacy. As a result, the agreement will empower the three parties to provide even better services to the biomedical community and to facilitate a more cost-effective research and development process.

The SCTO has been chosen by the State Secretariat for Education, Research and Innovation (SERI) to represent Switzerland in the ECRIN consortium. The ECRIN European Correspondent (EuCo) for Switzerland is based at the SCTO and coordinates fee-based services and support for scientific partner institutions nationally and internationally.

To read the press release about the agreement, visit eatris.eu.

Show more

Hide

The buzz words “patient engagement” are heard more and more often in research settings. But how is patient engagement really carried out, well and meaningfully? At the SCTO, our strategic objectives include prioritising patient empowerment and involvement, which incorporates identifying useful tools to this end.

To round off the past year, Patient Focused Medicines Development (PFMD) handpicked the five best key articles to help readers embark on patient-centred projects. The articles are published as 2018’s essential reads in patient engagement. They showcase the maturation of patient engagement and a collaborative, international move underway – from talking about it, to actually doing it.

Questions probed include:

• What does patient-led research really look like?
• What essential role can patients take in developing clinical recommendations that are fit for purpose?
• Can it be demonstrated that patient engagement activities can reduce protocol amendments and improve the recruitment, adherence, and retention of participants?
• And how can involving patients in trial design and in defining outcomes improve the quality and relevance of research to patients in tandem with their participation in trials?
   

To explore the answers to these questions, browse the 2018 essential reads at PFMD.

PFMD is an open, independent global coalition of health stakeholders. Founded in 2015, it aims to transform the way in which we understand, engage, and partner with patients globally in the design and development of research and medicines, by focusing on unmet patient needs.

Show more

Hide

The SCTO is included in an important listing. The newly updated International Compilation of Human Research Standards (2019 Edition), published by the U.S. Department of Health & Human Services (HHS), is a listing of more than 1,000 laws, regulations, and guidelines on the protection of human subjects (participants). It includes regional and international organisations from 131 countries.

The SCTO is proud to have been included for our Guidelines for Good Operational Practice (GGOP), representing a framework of common standards for professional and operational practice in clinical research. 

To access the compilation, visit the HHS.
Learn more about our GGOP under Publications.

Show more

Hide